Howard Goldsweig
Direttore Tecnico/Scientifico/R&S presso BioVex, Inc.
Profilo
Howard Goldsweig currently works at BioVex, Inc., as Chief Medical Officer from 2008.
Dr. Goldsweig also formerly worked at Wyeth Pharmaceuticals LLC, as Principal, BioVex Group, Inc., as Chief Medical Officer from 2008 to 2013, Hoffmann-La Roche, Inc., as Principal, Columbia Presbyterian Medical Center, as Principal, BioVex Ltd., as Chief Medical Officer, St. Luke's-Roosevelt Hospital Center, as Principal, and Averion International Corp., as Principal.
Dr. Goldsweig received his doctorate degree from The State University of New York.
Posizioni attive di Howard Goldsweig
| Società | Posizione | Inizio |
|---|---|---|
BioVex, Inc.
 BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Direttore Tecnico/Scientifico/R&S | 15/05/2009 |
Precedenti posizioni note di Howard Goldsweig
| Società | Posizione | Fine |
|---|---|---|
BioVex Group, Inc.
 BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Direttore Tecnico/Scientifico/R&S | 24/01/2013 |
St. Luke's-Roosevelt Hospital Center
 St. Luke's-Roosevelt Hospital Center Hospital/Nursing ManagementHealth Services St. Luke's-Roosevelt Hospital Center owns and operates a hospital. It provides services in the areas of emergency, pediatric emergency, pre-hospital care and medical toxicology. The company was founded in 1979 and is headquartered in New York, NY. | Corporate Officer/Principal | - |
Columbia Presbyterian Medical Center
 Columbia Presbyterian Medical Center Hospital/Nursing ManagementHealth Services Part of New York Hospital, Columbia Presbyterian Medical Center is a healthcare organization that includes hospitals, nursing homes, and ambulatory care centers. Columbia Presbyterian Medical Center was acquired by New York Hospital on July 25, 1996. | Corporate Officer/Principal | - |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Corporate Officer/Principal | - |
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Corporate Officer/Principal | - |
Formazione di Howard Goldsweig
| The State University of New York | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 8 |
|---|---|
BioVex Ltd.
 BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services BioVex Ltd. operates as a biotechnology firm. It focuses on the development and commercialization of biological treatments for cancer and the prevention of infectious disease. The company was founded on December 15, 1997 and is headquartered in Cambridge, the United Kingdom. | Commercial Services |
Averion International Corp.
 Averion International Corp. Miscellaneous Commercial ServicesCommercial Services Averion International Corp. provides clinical research services. It serves for pharmaceutical, biotechnology and medical device industries. The company mainly focuses on oncology, nephrology, dermatology and medical devices. The company was founded on April 22, 2002 and is headquartered in Southborough, MA. | Commercial Services |
Wyeth Pharmaceuticals LLC
Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. | Health Technology |
Hoffmann-La Roche, Inc.
Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Health Technology |
Columbia Presbyterian Medical Center
Columbia Presbyterian Medical Center Hospital/Nursing ManagementHealth Services Part of New York Hospital, Columbia Presbyterian Medical Center is a healthcare organization that includes hospitals, nursing homes, and ambulatory care centers. Columbia Presbyterian Medical Center was acquired by New York Hospital on July 25, 1996. | Health Services |
St. Luke's-Roosevelt Hospital Center
St. Luke's-Roosevelt Hospital Center Hospital/Nursing ManagementHealth Services St. Luke's-Roosevelt Hospital Center owns and operates a hospital. It provides services in the areas of emergency, pediatric emergency, pre-hospital care and medical toxicology. The company was founded in 1979 and is headquartered in New York, NY. | Health Services |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology BioVex, Inc. develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases. Its products include OncoVEX oncolytic and ImmunoVEX technology. The company was founded in 1999 by Dr. Robert Coffin and is headquartered in Woburn, MA. | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology BioVex Group, Inc. operates as a clinical-stage biotechnology company. It focuses on the development and commercialization of targeted treatments for cancer and the prevention of infectious disease. The company was founded in 1999 and is headquartered in Woburn, MA. | Health Technology |
- Borsa valori
- Insiders
- Howard Goldsweig
